Tanda-tanda anda menghadapi masalah MENTAL / Stress?
Posted On Saturday, July 12, 2008 at at 3:49 PM by Aishah Abd Latiff
Kedua: Tengkuk anda sentiasa merasa sakit dan susah untuk memusingkan kepala?
Ketiga: Rambut anda sentiasa kusut masai setelah mandi dan menggunakan syampu terbaik?
Keempat: Kepala anda sentiasa merasa pening dan seperti berada di awang-awangan?
Kelima: Berat badan anda terus meningkat dengan mendadak
walau pun telah berusaha keras untuk mengurangkan berat?
Keenam: Anda sentiasa merasa letih yang amat sangat dan sentiasa mengeliat?
Ketujuh: Anda sentiasa merasa fikiran terlalu sempit?
Kelapan: Anda sentiasa merasa diri anda terlalu kecil dan selalu dipermainkan?
Kesembilan: Boss sentiasa marah dengan anda?
Kesepuluh: Anda sentiasa basah kuyup ketika keluar makan tengahari walaupun berpayung?
Kesebelas: Anda sentiasa dan selalu merasa penat yang amat sangat?
Keduabelas: Anda sentiasa merasa diri tersepit?
Ketigabelas: Anda sentiasa merasa kehadiran tetamu asing?
Keempatbelas: Anda sentiasa merasa seperti hendak demam dan selsema serta kepala merasa panas?
Kelimabelas dan akhir: ANDA SENTIASA MERASA......KESEORANGAN DAN MERASA AMAT TAKUT ....... SEPERTI ADA SESEORANG BERADA DI DALAM RUMAH....... ......... ......... .HE...HE. ....HE... ..
Pfizer's Cholesterol Drug Boosts Death Rate by 58 Percent
Posted On Sunday, June 22, 2008 at at 2:48 PM by Aishah Abd Latiff
Researchers studied 15,067 participants, all considered to be at high risk of cardiovascular disease. All the patients were treated with the cholesterol-lowering drug atorvastatin, while half were also treated with torcetrapid.
Torcetrapid is marketed by Pfizer, as is atorvastatin (under the brand name Lipitor).
Patients receiving both drugs had a 58 percent higher chance of dying and a 25 percent higher chance of experiencing cardiovascular events such as heart attacks than those who were treated only with atorvastatin.
Torcetrapid is one of a new class of drugs called cholesteryl ester transfer protein (CETP) inhibitors. Unlike older cholesterol drugs, which only lower LDL levels, CETP inhibitors are intended to raise HDL levels at the same time. The drugs function by blocking the action of a protein that transfers cholesterol from HDL to LDL, thus forcing the cholesterol to remain in HDL form.
In the recent study, torcetrapid was found to raise HDL levels by an average of 72.1 percent, and lower LDL levels by an average of 24.9 percent.
Scientists are still unclear why torcetrapid appears to increase patient death rates and heart attack risk. While the drug is known to raise blood pressure, many of the patients who died in the recent study actually had blood pressure levels below normal.
Researchers have hypothesized that the drug may increase the levels of a hormone involved in regulating blood pressure, and that this may lead to stress on the cardiovascular system.
Merck and Roche Holding have placed the development of their own CETP inhibitors on hold, pending the results of further trials on torcetrapid.
by David Gutierrez
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml
